Coinbase shares jumped Thursday after the market close after reporting Q2 earnings and revenues that beat analyst estimates. $COIN By NelWang
Coinbase shares jumped Thursday after the market close as the crypto exchange reported revenues of $708 million and adjusted earnings of a loss of $0.42, beating analyst estimates of revenues of $628 million and earnings per share of a loss of $0.76.
Transaction revenue came in at $327 million, compared to $375 million in the first quarter, while total trading volume fell to $92 billion, compared to $145 billion in the first quarter. Interest income fell to $201 million from $241 million in Q1. Of that interest income in Q2, $151 million came from its holdings of USDC.
Shares of Coinbase were rising 5.5% to $95.60 in after-hours trading Thursday. Shares of Coinbase are up about 160% this year, while the price of bitcoin has risen more than 75% over the same time period. “Q2 was a strong quarter for Coinbase as we executed well and showed resilience in a challenging environment,” said CEO Brian Armstrong. “We’ve cut costs, are operating efficiently, and remain well-positioned to build the future of the crypto economy and help drive regulatory clarity.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Upbit exchange overtakes Coinbase and OKX in trading volumeUpbit’s overall trading volume overtakes OKX and Coinbase - making it the second-largest exchange by trading volume after Binance, according to data from CCData.
続きを読む »
Coinbase Market Share in US Rises to 61% Despite SEC LawsuitCoinbase crypto exchange grows US market share to 61% despite SEC lawsuit
続きを読む »
Albemarle boosts profit forecast on surging lithium demand, shares jumpAlbemarle Corp , the world's largest producer of lithium, raised its 2023 profit forecast on Wednesday after reporting better-than-expected quarterly results, and it shares jumped as the company cited rising global appetite for the metal used to make electric vehicle batteries.
続きを読む »
Regeneron expects FDA decision on high-dose eye drug this year, shares jumpRegeneron Pharmaceuticals expects a U.S. decision on a higher-dose version of its blockbuster eye disease drug Eylea in the third quarter, much earlier than market expectations, sending its shares 5% higher in premarket trading on Thursday.
続きを読む »
AMD shares rise as chipmaker tops expectations, Starbucks shares fall and other stocks on the moveAMD, Match Group, Starbucks and Electronic Arts are on the move.
続きを読む »
Coinbase Looks to Add Bitcoin Lightning for Payments.Coinbase is looking to add Bitcoin Lightning payments as part of a broader plan to offer more crypto payments for its users, CEO brian_armstrong said. By shauryamalwa.
続きを読む »